One of the newest medications on the market is Ozempic, a drug purported to help obese and Type 2 diabetes patients lose weight
As Web 1.0 mania inflated, Broadcast.com recorded the best-ever IPO at the time, ending its first trading day with a market cap of $1 billion, more than 300 times its sales of $3.2 million
But even that was hard to find
As of 2025, 43% of very large employers (5,000+ workers) cover GLP-1 medications for weight loss, up from 28% in 2024
It acts on the reward center in the brain, diminishing the pleasurable response to certain foods, particularly those high in sugar and fat
Improved health: Weight loss can lead to reduced risk factors for obesity-related conditions like diabetes and heart disease